文献速递临床试验与 GCP

比较手术与综合物理减容疗法治疗脂肪水肿疗效与安全性的随机对照多中心研究者盲法临床试验(LIPLEG)

A randomised controlled multicentre investigator-blinded clinical trial comparing efficacy and safety of surgery versus complex physical decongestive therapy for lipedema (LIPLEG).
PubMed 文献 · Trials · 2021-10-30

LIPLEG是一项随机对照多中心研究者盲法试验,拟纳入405例无脂肪抽吸史的脂肪水肿女性,按2:1分配至脂肪抽吸术或综合减容疗法(CDT)。主要结局为12个月时腿痛视觉模拟量表(0-10分)降低≥2分,主要分析基于意向性治疗,采用Mantel-Haenszel检验按脂肪水肿分期分层,双侧显著性水平5%。

要点

  • LIPLEG试验比较脂肪抽吸术与综合减容疗法(CDT)治疗脂肪水肿的疗效与安全性。
  • 拟纳入405例无脂肪抽吸史的女性脂肪水肿患者,按2:1随机分配至脂肪抽吸术或CDT。
  • 主要结局为12个月时腿痛视觉模拟量表(0-10分)降低≥2分。

核心结论

  • LIPLEG试验评估脂肪水肿手术治疗是否安全有效,能否减轻疼痛及其他脂肪水肿相关健康问题。
  • 该试验结果有潜力改变脂肪水肿的标准治疗。

研究设计与样本

  • 随机对照多中心研究者盲法临床试验,拟纳入405例无脂肪抽吸史的女性脂肪水肿患者,按2:1分配至脂肪抽吸术或综合减容疗法(CDT)。

关键数值与推荐

  • 主要结局为12个月时(CDT组或脂肪抽吸术完成后)腿痛视觉模拟量表(0-10分)降低≥2分。
  • 次要结局包括腿痛严重程度、健康相关生活质量、抑郁倾向、血肿倾向、水肿患病率、物理治疗范围调整、体脂百分比、腿围和活动受限的变化。
  • 主要分析基于意向性治疗,采用Mantel-Haenszel检验按脂肪水肿分期分层比较成功比例,双侧显著性水平为5%。
  • 若Mantel-Haenszel检验有统计学意义,则按分层检验策略采用Fisher精确检验评估各层反应比例是否相等。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Lipedema is a chronic disorder of the adipose tissue that affects mainly women, characterised by symmetrical, excessive fatty tissue on the legs and pain. Standard conservative treatment is long-term comprehensive decongestive therapy (CDT) to alleviate lipedema-related pain and to improve psychosocial well-being, mobility and physical activity. Patients may benefit from surgical removal of abnormally propagated adipose tissue by liposuction. The LIPLEG trial evaluates the efficacy and safety of liposuction compared to standard CDT. METHODS/DESIGN: LIPLEG is a randomised controlled multicentre investigator-blinded trial. Women with lipedema (n=405) without previous liposuction will be allocated 2:1 to liposuction or CDT. The primary outcome of the trial is leg pain reduction by ≥2 points on a visual analogue scale ranging 0-10 at 12 months on CDT or post-completion of liposuction. Secondary outcomes include changes in leg pain severity, health-related quality of life, depression tendency, haematoma tendency, prevalence of oedema, modification physical therapy scope, body fat percentage, leg circumference and movement restriction. The primary analysis bases on intention-to-treat. Success proportions are compared using the Mantel-Haenszel test stratified by lipedema stage at a 5% two-sided significance level. If this test is statistically significant, the equality of the response proportions in the separate strata is evaluated by Fisher's exact test in a hierarchical test strategy. DISCUSSION: LIPLEG assesses whether surgical treatment of lipedema is safe and effective to reduce pain and other lipedema-related health issues. The findings of this trial have the potential to change the standard of care in lipedema. TRIAL REGISTRATION: ClinicalTrials.gov NCT04272827. Registered on February 14, 2020. TRIAL STATUS: Protocol version is 02_0, December 17, 2019.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Podda M, Kovacs M, Hellmich M, et al. A randomised controlled multicentre investigator-blinded clinical trial comparing efficacy and safety of surgery versus complex physical decongestive therapy for lipedema (LIPLEG). Trials. 2021. PMID: 34717741. doi:10.1186/s13063-021-05727-2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。